BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kakiuchi T, Matsuo M, Endo H, Nakayama A, Sato K, Takamori A, Sasaki K, Takasaki M, Hara M, Sakata Y, Okuda M, Kikuchi S, Eguchi Y, Takahashi H, Anzai K, Fujimoto K. A Helicobacter pylori screening and treatment program to eliminate gastric cancer among junior high school students in Saga Prefecture: a preliminary report. J Gastroenterol 2019;54:699-707. [DOI: 10.1007/s00535-019-01559-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Kakiuchi T, Tanaka Y, Ohno H, Matsuo M, Fujimoto K. Helicobacter pylori infection-induced changes in the intestinal microbiota of 14-year-old or 15-year-old Japanese adolescents: a cross-sectional study. BMJ Open 2021;11:e047941. [PMID: 34215607 DOI: 10.1136/bmjopen-2020-047941] [Reference Citation Analysis]
2 Peng C, Hu Y, Ge ZM, Zou QM, Lyu NH. Diagnosis and treatment of Helicobacter pylori infections in children and elderly populations. Chronic Dis Transl Med 2019;5:243-51. [PMID: 32055783 DOI: 10.1016/j.cdtm.2019.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
3 Kakiuchi T, Takamori A, Matsuo M. High Prevalence of Helicobacter pylori Infection in Special Needs Schools in Japan. Front Pediatr 2021;9:697200. [PMID: 34307259 DOI: 10.3389/fped.2021.697200] [Reference Citation Analysis]
4 Abe Y, Kusano C, Takano C, Morioka I, Gotoda T. Association between Helicobacter pylori antibody-positive status and extragastric diseases in Japanese junior high school students. Pediatr Int 2021;63:1087-94. [PMID: 33351269 DOI: 10.1111/ped.14585] [Reference Citation Analysis]
5 Kakiuchi T, Matsuo M, Sakata Y, Fujimoto K, Granito A. Clinical Evaluation of a Novel Stool Antigen Test Using Bioluminescent Enzyme Immunoassay for Detecting Helicobacter pylori. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-8. [DOI: 10.1155/2022/5571542] [Reference Citation Analysis]
6 Okuda M, Lin Y, Kikuchi S. Helicobacter pylori Infection in Children and Adolescents. Adv Exp Med Biol. 2019;1149:107-120. [PMID: 31037557 DOI: 10.1007/5584_2019_361] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
7 Kakiuchi T, Nakayama A, Shimoda R, Matsuo M. Atrophic gastritis and chronic diarrhea due to Helicobacter pylori infection in early infancy: A case report. Medicine (Baltimore) 2019;98:e17986. [PMID: 31764809 DOI: 10.1097/MD.0000000000017986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut 2020;69:2113-21. [PMID: 32205420 DOI: 10.1136/gutjnl-2020-320839] [Cited by in Crossref: 80] [Cited by in F6Publishing: 61] [Article Influence: 40.0] [Reference Citation Analysis]
9 Mišak Z, Hojsak I, Homan M. Review: Helicobacter pylori in pediatrics. Helicobacter 2019;24 Suppl 1:e12639. [PMID: 31486243 DOI: 10.1111/hel.12639] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
10 Xiang W, Wang R, Bai D, Yu T, Chen X; on behalf of the SIGES Research Groups. Helicobacter Pylori Related Gastric Cancer Screening and Cost-Effectiveness Analysis: A Hospital-Based Cross-Sectional Study (SIGES). Nutrition and Cancer. [DOI: 10.1080/01635581.2021.2022168] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Mărginean CO, Meliț LE, Săsăran MO. Gastric Microenvironment-A Partnership between Innate Immunity and Gastric Microbiota Tricks Helicobacter pylori. J Clin Med 2021;10:3258. [PMID: 34362042 DOI: 10.3390/jcm10153258] [Reference Citation Analysis]
12 Kakiuchi T, Hashiguchi K, Imamura I, Nakayama A, Takamori A, Okuda M, Matsuo M. Assessment of a novel method to detect clarithromycin-resistant Helicobacter pylori using a stool antigen test reagent. BMC Gastroenterol 2020;20:397. [PMID: 33228552 DOI: 10.1186/s12876-020-01549-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Argueta EA, Moss SF. Management of Helicobacter pylori. Curr Opin Gastroenterol 2020;36:518-24. [PMID: 32868505 DOI: 10.1097/MOG.0000000000000678] [Reference Citation Analysis]
14 Kakiuchi T, Yamamoto K, Imamura I, Hashiguchi K, Kawakubo H, Yamaguchi D, Fujioka Y, Okuda M. Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study. Sci Rep 2021;11:755. [PMID: 33436953 DOI: 10.1038/s41598-020-80802-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Gotoda T, Kusano C, Suzuki S, Horii T, Ichijima R, Ikehara H. Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan. J Gastroenterol 2020;55:969-76. [DOI: 10.1007/s00535-020-01709-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
16 Kawai S, Wang C, Lin Y, Sasakabe T, Okuda M, Kikuchi S. Lifetime incidence risk for gastric cancer in the Helicobacter pylori-infected and uninfected population in Japan: A Monte Carlo simulation study. Int J Cancer 2022;150:18-27. [PMID: 34449868 DOI: 10.1002/ijc.33773] [Reference Citation Analysis]
17 Kaji E, Yoden A, Otani M, Okuhira T, Aomatsu T, Tamai H, Ashida A. Helicobacter pylori test-and-treat strategy for second-year junior high school students aimed at the prevention of gastric cancer in Takatsuki City. Helicobacter 2020;25:e12696. [PMID: 32352203 DOI: 10.1111/hel.12696] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Kakiuchi T, Matsuo M, Endo H, Sakata Y, Esaki M, Noda T, Imamura I, Hashiguchi K, Ogata S, Fujioka Y, Hanada K, Fukuda K, Yoshimura M, Kajiwara T, Yamamoto K, Yamaguchi D, Kawakubo H, Akashi T, Sumino M, Matsunaga K, Muro E, Kuwahara A, Taniguchi K, Fukuyama K, Watanabe A, Takamori A, Okuda M, Yamanouchi K, Fujimoto K. Gastrointestinal adverse reactions reduce the success rate of Helicobacter pylori eradication therapy: A multicenter prospective cohort study. Helicobacter 2021;26:e12776. [PMID: 33368891 DOI: 10.1111/hel.12776] [Reference Citation Analysis]
19 Fujimoto S, Tsuruoka N, Esaki M, Takamori A, Sakata Y, Shimoda R, Akutagawa T, Node K, Anzai K, Sugisaki N, Iwakiri R, Takagi K, Yamanouchi K, Fujimoto K. Decline incidence in upper gastrointestinal bleeding in several recent years: data of the Japan claims database of 13 million accumulated patients. J Clin Biochem Nutr 2021;68:95-100. [PMID: 33536718 DOI: 10.3164/jcbn.20-153] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]